Commentary: PCP4 inhibits the progression of prostate cancer through Ca2+/CAMKK2/AMPK/AR pathway - Quiz - MDSpire

Commentary: PCP4 inhibits the progression of prostate cancer through Ca2+/CAMKK2/AMPK/AR pathway

  • By

  • Wujie Chen

  • Fajiang Qian

  • Fengtong Wang

  • Fuquan Yang

  • Yuqing Shen

  • Mingxia Ding

  • Yuan Liu

  • July 3, 2026

  • 0 min

Share

Original Source(s)

Commentary: PCP4 inhibits the progression of prostate cancer through Ca2+/CAMKK2/AMPK/AR pathway

  • by Wujie Chen, Fajiang Qian, Fengtong Wang, Fuquan Yang, Yuqing Shen, Mingxia Ding, Yuan Liu

  • July 3, 2026

Related Content

Correction: miR-1323 promotes cell migration in lung adenocarcinoma by targeting Cbl-b and is an early prognostic biomarker

Transrectal vs. transvaginal oocyte retrieval in patients requesting egg freezing for fertility preservation: a prospective observational study

Efficacy and safety of acupuncture for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trial